Literature DB >> 12126146

Primary infection, latency, and reactivation of bovine herpesvirus type 5 in the bovine nervous system.

S E Perez1, G Bretschneider, M R Leunda, E A Osorio, E F Flores, A C Odeón.   

Abstract

Bovine herpesvirus type 5 (BHV-5) infection in calves causes meningoencephalitis, a fatal disease highly prevalent in South America. To study the pathogenesis of BHV-5 infection in cattle, 12 calves (group 1: acute infection) and 11 calves (group 2: latent infection) were intranasally inoculated with an Argentinean BHV-5 isolate at 10(8) and 10(4.7) tissue culture infective doses, respectively; six calves (control group) were mock infected. At 3 months postinoculation, all of the calves in group 2 and three calves in group 3 were given dexamethasone to reactivate the virus. The animals were euthanatized between days 6 and 17 postinoculation (group 1) and between days 6 and 16 postreactivation (group 2). Seventy-five percent and 91% of animals in groups 1 and 2, respectively, excreted BHV-5 in nasal and ocular discharges. Following dexamethasone administration, 45% of calves shed virus in both types of secretions. Spontaneous virus reactivation and shedding was observed in one calf. Neurologic signs consisting of circling, teeth grinding, ptyalism, jaw chomping, tongue protrusion, and apathy were observed in two animals in group 1 and, during the reactivation period, in four animals in group 2. Macroscopic findings consisted of softening of the cerebral tissue, meningeal hemorrhages and swelling, and edema and hemorrhages of prescapular, retropharyngeal and submandibular lymph nodes. Histologic lesions consisted of meningitis, mononuclear perivascular cuffing, neuronophagia, satellitosis, gliosis, hemorrhage, and necrosis and edema. Lesions in anterior cerebral cortex, medulla, and pons were consistently seen in all the animals of group 1. In the acutely infected animals, lesions in the diencephalon appeared at day 10 postinoculation, whereas in the latently infected calves these lesions were observed as early as at day 6 postreactivation. Latently infected animals developed lesions simultaneously in anterior cortex, medulla, pons, and diencephalon, showing a remarkable difference from the acutely infected group. Trigeminal ganglionitis appeared relatively early in animals of both groups (day 7 postinoculation in group 1 and day 8 postreactivation in group 2).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126146     DOI: 10.1354/vp.39-4-437

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  13 in total

1.  Susceptibility of mice to bovine herpesvirus type 5 infection in the central nervous system.

Authors:  L P Mesquita; R C Costa; M M Fusuma; F R P Bruhn; E Mori; E M Pituco; C M C Mori; R Weiblen; P C Maiorka
Journal:  Vet Res Commun       Date:  2017-09-23       Impact factor: 2.459

2.  NTPDase and 5'-nucleotidase activities in synaptosomes of rabbits experimentally infected with BoHV-5.

Authors:  Cássia B da Silva; Francine C Paim; Patricia Wolkmer; Fátima H Abdalla; Fabiano B Carvalho; Heloísa H Palma; Camila B E Mello; Eduardo F Flores; Cinthia M Andrade; Sonia T A Lopes
Journal:  J Neurovirol       Date:  2015-05-30       Impact factor: 2.643

3.  Asymptomatic encephalitis in calves experimentally infected with bovine herpesvirus-5.

Authors:  Allan Jürgen Isernhagen; Mariana Cosenza; Marcio Carvalho da Costa; Kerlei Cristina Médici; Mara Regina Stipp Balarin; Ana Paula Frederico Rodrigues Loureiro Bracarense; Amauri Alcindo Alfieri; Júlio Augusto Naylor Lisbôa
Journal:  Can Vet J       Date:  2011-12       Impact factor: 1.008

4.  Functional analysis of the latency-related gene of bovine herpesvirus types 1 and 5.

Authors:  Carolina Silvestro; Clinton Jones; Ana Bratanich
Journal:  J Neurovirol       Date:  2019-05-06       Impact factor: 2.643

5.  Genome of bovine herpesvirus 5.

Authors:  G Delhon; M P Moraes; Z Lu; C L Afonso; E F Flores; R Weiblen; G F Kutish; D L Rock
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Immunohistochemical approach to the pathogenesis of clinical cases of bovine Herpesvirus type 5 infections.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Livia C Bregano; Alexandre L Andrade; Adriana Hc Nogueira
Journal:  Diagn Pathol       Date:  2010-09-10       Impact factor: 2.644

7.  Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves.

Authors:  Fernanda Silveira Flôres Vogel; Luizinho Caron; Eduardo Furtado Flores; Rudi Weiblen; Evandro Reinoldo Winkelmann; Sandra Vanderli Mayer; Reginaldo Gaspar Bastos
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

8.  Detection methods and characterization of bovine viral diarrhea virus in aborted fetuses and neonatal calves over a 22-year period.

Authors:  Maximiliano J Spetter; Enrique L Louge Uriarte; Joaquín I Armendano; Eleonora L Morrell; Germán J Cantón; Andrea E Verna; Matías A Dorsch; Susana B Pereyra; Anselmo C Odeón; Jeremiah T Saliki; Erika A González Altamiranda
Journal:  Braz J Microbiol       Date:  2020-05-16       Impact factor: 2.476

9.  Brain-derived neurotrophic factor is down regulated after bovine alpha-herpesvirus 5 infection in both wild-type and TLR3/7/9 deficient mice.

Authors:  Daniele Gonçalves DA Silva; Iracema Luisa Quintino de Carvalho; Eliana Cristina de Brito Toscano; Beatriz Álvares da Silva Senra Santos; Bruna da Silva Oliveira; Marco Antônio Campos; Flávio Guimarães da Fonseca; Quezya Mendes Camargos; Gabriela Ferreira de Sousa; Marcelo Vidigal Caliari; Antônio Lúcio Teixeira; Aline Silva de Miranda; Milene Alvarenga Rachid
Journal:  J Vet Med Sci       Date:  2020-12-07       Impact factor: 1.267

10.  Susceptibility of neuron-like cells derived from bovine Wharton's jelly to bovine herpesvirus type 5 infections.

Authors:  Tereza C Cardoso; Juliana B Novais; Talita F Antello; Camila Silva-Frade; Marina C Ferrarezi; Heitor F Ferrari; Roberto Gameiro; Eduardo F Flores
Journal:  BMC Vet Res       Date:  2012-12-10       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.